{"id":"W3006286575","doi":"10.1002/hon.2723","title":"Final analysis of a phase 1/2b study of ibrutinib combined with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma","year":2020,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Carfilzomib; Ibrutinib; Medicine; Dexamethasone; Refractory (planetary science); Multiple myeloma; Oncology; Internal medicine; Lenalidomide; Leukemia; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001906158,0.0002651221,0.002029407,0.0003716269,0.00003672243,0.000003529973,0.0001630796,0.0001933758,0.0002815618],"category_scores_gemma":[0.0007222465,0.0001579405,0.0001313617,0.001598396,0.000298351,0.00005345845,0.00009804327,0.0003886598,0.000006821278],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001109898,"about_ca_system_score_gemma":0.0002042172,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000154446,"about_ca_topic_score_gemma":0.0003879615,"domain_scores_codex":[0.9973365,0.0003933605,0.0007299866,0.0005379478,0.0005896975,0.0004124838],"domain_scores_gemma":[0.9977365,0.000862162,0.0003943561,0.00035738,0.0002905045,0.0003590859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06776069,0.03093045,0.8942095,0.00009660218,0.00225868,0.001176761,0.0009757481,0.00004037723,0.00023941,0.00002190046,0.00002636183,0.002263498],"study_design_scores_gemma":[0.09147003,0.09597009,0.8086023,0.00003936353,0.001133054,0.000008841667,0.0007990496,0.001396582,0.0003987292,0.000002462471,0.00004894002,0.0001305125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976181,0.00004309259,0.00005774191,0.0002513623,0.00001133537,0.001653404,0.00004792069,0.00003282415,0.000284221],"genre_scores_gemma":[0.9977885,0.000005676574,0.001799947,0.0001126986,0.000007412089,0.0001115919,0.0001437667,0.00001740035,0.00001301483],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08560719,"threshold_uncertainty_score":0.6440625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06631480899877269,"score_gpt":0.3511896877632336,"score_spread":0.2848748787644609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}